Copyright Reports & Markets. All rights reserved.

Global Non-Invasive Prenatal Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Non-Invasive Prenatal Testing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 High & Average Risk
    • 1.4.3 Low Risk
  • 1.5 Market by Application
    • 1.5.1 Global Non-Invasive Prenatal Testing Market Share by Application: 2020 VS 2026
    • 1.5.2 0-12 weeks
    • 1.5.3 13-24 weeks
    • 1.5.4 25-36 weeks
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Non-Invasive Prenatal Testing Market Perspective (2015-2026)
  • 2.2 Global Non-Invasive Prenatal Testing Growth Trends by Regions
    • 2.2.1 Non-Invasive Prenatal Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Non-Invasive Prenatal Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Non-Invasive Prenatal Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Non-Invasive Prenatal Testing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Non-Invasive Prenatal Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Non-Invasive Prenatal Testing Players by Market Size
    • 3.1.1 Global Top Non-Invasive Prenatal Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Non-Invasive Prenatal Testing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Non-Invasive Prenatal Testing Market Concentration Ratio
    • 3.2.1 Global Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Testing Revenue in 2019
  • 3.3 Non-Invasive Prenatal Testing Key Players Head office and Area Served
  • 3.4 Key Players Non-Invasive Prenatal Testing Product Solution and Service
  • 3.5 Date of Enter into Non-Invasive Prenatal Testing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Non-Invasive Prenatal Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Non-Invasive Prenatal Testing Market Size by Application (2015-2020)
  • 5.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Non-Invasive Prenatal Testing Market Size (2015-2020)
  • 6.2 Non-Invasive Prenatal Testing Key Players in North America (2019-2020)
  • 6.3 North America Non-Invasive Prenatal Testing Market Size by Type (2015-2020)
  • 6.4 North America Non-Invasive Prenatal Testing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Non-Invasive Prenatal Testing Market Size (2015-2020)
  • 7.2 Non-Invasive Prenatal Testing Key Players in Europe (2019-2020)
  • 7.3 Europe Non-Invasive Prenatal Testing Market Size by Type (2015-2020)
  • 7.4 Europe Non-Invasive Prenatal Testing Market Size by Application (2015-2020)

8 China

  • 8.1 China Non-Invasive Prenatal Testing Market Size (2015-2020)
  • 8.2 Non-Invasive Prenatal Testing Key Players in China (2019-2020)
  • 8.3 China Non-Invasive Prenatal Testing Market Size by Type (2015-2020)
  • 8.4 China Non-Invasive Prenatal Testing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Non-Invasive Prenatal Testing Market Size (2015-2020)
  • 9.2 Non-Invasive Prenatal Testing Key Players in Japan (2019-2020)
  • 9.3 Japan Non-Invasive Prenatal Testing Market Size by Type (2015-2020)
  • 9.4 Japan Non-Invasive Prenatal Testing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Non-Invasive Prenatal Testing Market Size (2015-2020)
  • 10.2 Non-Invasive Prenatal Testing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Non-Invasive Prenatal Testing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Non-Invasive Prenatal Testing Market Size by Application (2015-2020)

11 India

  • 11.1 India Non-Invasive Prenatal Testing Market Size (2015-2020)
  • 11.2 Non-Invasive Prenatal Testing Key Players in India (2019-2020)
  • 11.3 India Non-Invasive Prenatal Testing Market Size by Type (2015-2020)
  • 11.4 India Non-Invasive Prenatal Testing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Non-Invasive Prenatal Testing Market Size (2015-2020)
  • 12.2 Non-Invasive Prenatal Testing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Non-Invasive Prenatal Testing Market Size by Type (2015-2020)
  • 12.4 Central & South America Non-Invasive Prenatal Testing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Sequenom
    • 13.1.1 Sequenom Company Details
    • 13.1.2 Sequenom Business Overview
    • 13.1.3 Sequenom Non-Invasive Prenatal Testing Introduction
    • 13.1.4 Sequenom Revenue in Non-Invasive Prenatal Testing Business (2015-2020))
    • 13.1.5 Sequenom Recent Development
  • 13.2 Roche
    • 13.2.1 Roche Company Details
    • 13.2.2 Roche Business Overview
    • 13.2.3 Roche Non-Invasive Prenatal Testing Introduction
    • 13.2.4 Roche Revenue in Non-Invasive Prenatal Testing Business (2015-2020)
    • 13.2.5 Roche Recent Development
  • 13.3 Natera
    • 13.3.1 Natera Company Details
    • 13.3.2 Natera Business Overview
    • 13.3.3 Natera Non-Invasive Prenatal Testing Introduction
    • 13.3.4 Natera Revenue in Non-Invasive Prenatal Testing Business (2015-2020)
    • 13.3.5 Natera Recent Development
  • 13.4 LabCorp
    • 13.4.1 LabCorp Company Details
    • 13.4.2 LabCorp Business Overview
    • 13.4.3 LabCorp Non-Invasive Prenatal Testing Introduction
    • 13.4.4 LabCorp Revenue in Non-Invasive Prenatal Testing Business (2015-2020)
    • 13.4.5 LabCorp Recent Development
  • 13.5 BGI Genomics
    • 13.5.1 BGI Genomics Company Details
    • 13.5.2 BGI Genomics Business Overview
    • 13.5.3 BGI Genomics Non-Invasive Prenatal Testing Introduction
    • 13.5.4 BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2015-2020)
    • 13.5.5 BGI Genomics Recent Development
  • 13.6 Quest Diagnostics
    • 13.6.1 Quest Diagnostics Company Details
    • 13.6.2 Quest Diagnostics Business Overview
    • 13.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Introduction
    • 13.6.4 Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2015-2020)
    • 13.6.5 Quest Diagnostics Recent Development
  • 13.7 Illumina
    • 13.7.1 Illumina Company Details
    • 13.7.2 Illumina Business Overview
    • 13.7.3 Illumina Non-Invasive Prenatal Testing Introduction
    • 13.7.4 Illumina Revenue in Non-Invasive Prenatal Testing Business (2015-2020)
    • 13.7.5 Illumina Recent Development
  • 13.8 Berry Genomics
    • 13.8.1 Berry Genomics Company Details
    • 13.8.2 Berry Genomics Business Overview
    • 13.8.3 Berry Genomics Non-Invasive Prenatal Testing Introduction
    • 13.8.4 Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2015-2020)
    • 13.8.5 Berry Genomics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Non-Invasive Prenatal Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Prenatal Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Sequenom
    Roche
    Natera
    LabCorp
    BGI Genomics
    Quest Diagnostics
    Illumina
    Berry Genomics

    Market segment by Type, the product can be split into
    High & Average Risk
    Low Risk
    Market segment by Application, split into
    0-12 weeks
    13-24 weeks
    25-36 weeks

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now